{
    "clinical_study": {
        "@rank": "126075", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "IV formulation"
            }, 
            {
                "arm_group_label": "Melatonin 10 mg", 
                "arm_group_type": "Active Comparator", 
                "description": "IV formulation, Melatonin 10 mg"
            }, 
            {
                "arm_group_label": "Melatonin 100 mg", 
                "arm_group_type": "Active Comparator", 
                "description": "IV formulation, Melatonin 100 mg"
            }
        ], 
        "brief_summary": {
            "textblock": "A study investigating the analgesic effect of melatonin in a human heat injury model using\n      quantitative sensory testing."
        }, 
        "brief_title": "The Analgesic Effects of Melatonin", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Analgesia", 
            "Antihyperalgesia"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy males aged between 20 and 40 years\n\n        Exclusion Criteria:\n\n          -  Under aged/minors\n\n          -  Does not speak or understand danish\n\n          -  Alcohol or abuse of medicines\n\n          -  Prior QST-trial within the last 2 month\n\n          -  Prior medical trail within the last month\n\n          -  Serious comorbidity (ASA-class 3-4)\n\n          -  Chronic pain (defined by analgesic treatment) Shift-work or night work within the\n             last 14 days Known sleep-disorder"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01923974", 
            "org_study_id": "CPO-2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Melatonin 10 mg", 
                "intervention_name": "Melatonin 10 mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Melatonin 100 mg", 
                "intervention_name": "Melatonin 100 mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Analgesics", 
                "Melatonin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 24, 2014", 
        "location": {
            "contact": {
                "email": "lphandersen@gmail.com", 
                "last_name": "Lars P.H. Andersen, M.D.", 
                "phone": "31518908"
            }, 
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2200"
                }, 
                "name": "Multidisciplinary Pain Center 7612, Neuroscience Center, Rigshospitalet"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Analgesic Effects of Melatonin: A Randomized, Placebo-controlled, Double-blinded Study on Healthy Volunteers", 
        "overall_contact": {
            "email": "lphandersen@gmail.com", 
            "last_name": "Lars P.H. Andersen, MD", 
            "phone": "4531518908"
        }, 
        "overall_official": {
            "affiliation": "Herlev Hospital", 
            "last_name": "Lars P.H. Andersen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: The Regional Committee on Biomedical Research Ethics", 
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: Danish Medicines Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Pain (VAS)", 
                "safety_issue": "No", 
                "time_frame": "During burn injury. 1 hours following melatonin/placebo administration"
            }, 
            {
                "description": "Areas of secondary hyperalgesia will be assessed by quantitative sensory testing", 
                "measure": "Change in areas of secondary hyperalgesia", 
                "safety_issue": "No", 
                "time_frame": "1,2,4,6 hours following burn injury, which corresponds to 2,3,5 and 7 hours after melatonin/placebo-administration"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01923974"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Herlev Hospital", 
            "investigator_full_name": "Lars Peter Holst Andersen", 
            "investigator_title": "Ph.d. fellow", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in erythema/oedema assessed by ultrasound", 
                "safety_issue": "No", 
                "time_frame": "1,2,4,6 hours following burn injury, which corresponds to 2,3,5 and 7 hours after melatonin/placebo-administration"
            }, 
            {
                "measure": "Thermal thresholds assessed by quantitative sensory testing", 
                "safety_issue": "No", 
                "time_frame": "1,2,4,6 hours following burn injury, which corresponds to 2,3,5 and 7 hours after melatonin/placebo-administration"
            }, 
            {
                "measure": "Mechanical thresholds assessed quantitative sensory testing", 
                "safety_issue": "No", 
                "time_frame": "1,2,4,6 hours following burn injury, which corresponds to 2,3,5 and 7 hours after melatonin/placebo-administration"
            }
        ], 
        "source": "Herlev Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Lars Peter Holst Andersen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}